Advertisement

Acta Neurochirurgica

, Volume 148, Issue 3, pp 277–285 | Cite as

Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study

  • C. Chaskis
  • T. Stadnik
  • A. Michotte
  • K. Van Rompaey
  • J. D’Haens
Clinical Article

Summary

Object. Biopsy targeting based on MR imaging alone may fail to identify malignant areas in brain gliomas. Considering the differences in relative Cerebral Blood Volume (rCBV) ratios reported among tumour grades, we evaluated whether perfusion-weighted MR imaging (PWI) could usefully implement the routine preoperative imaging by detecting those areas bearing a higher yield for malignancy to guide the stereotactic biopsy or the surgical removal.

Clinical material and methods. We studied a series of 55 consecutive patients with newly diagnosed brain glioma using both conventional MR imaging and PWI in the preoperative assessment. The pathological diagnosis was established by stereotactic biopsy in 29 cases and by craniotomy in 24 cases. We evaluated the patient survival to detect undergrading.

Discussion. Independent from contrast-enhancement, perfusion-weighted MR imaging improved the target selection in stereotactic biopsy guidance and the removal of malignant areas in tumours amenable to surgery. Particularly sensitive to the perfused part of the tumour as to small regional changes, rCBV maps allowed a better detection of malignant areas. The rCBV ratios correlated significantly to the tumour grade and the final outcome (p < 0.01).

Conclusions. We found PWI valuable in the preoperative assessment of brain gliomas, discriminating high from low-grade gliomas. PWI can easily be performed on widely available MR imaging systems as part of the routine imaging of gliomas.

Keywords: Glioma; perfusion imaging; prognosis. 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aronen, HJ, Gazit, IE, Louis, DN, Buchbinder, BR, Pardo, FS, Weisskoff, RM, Harsh, GR, Cosgrove, GR, Halpern, EF, Hochberg, FH 1994Cerebral blood volume maps of gliomas: comparison with tumour grade and histologic findings.Radiology1914151PubMedGoogle Scholar
  2. Aronen, HJ, Glass, J, Pardo, FS, Belliveau, JW, Gruber, ML, Buchbinder, BR, Gazit, IE, Linggood, RM, Fischman, AJ, Rosen, BR 1995Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility.Acta Radiol36520528PubMedGoogle Scholar
  3. Asari, S, Makabe, T, Katayama, S, Itoh, T, Tsuchida, S, Ohmoto, T 1994Assessment of the pathological grade of astrocytic gliomas using an MRI score.Neuroradiology36308310CrossRefPubMedGoogle Scholar
  4. Barker, FG,2nd, Chang, SM, Huhn, SL, Davis, RL, Gutin, PH, McDermott, MW, Wilson, CB, Prados, MD 1997Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors.Cancer80936941CrossRefPubMedGoogle Scholar
  5. Batra, A, Tripathi, RP, Singh, AK 2004Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging.Australasian Radiology48324332PubMedGoogle Scholar
  6. Benard, F, Romsa, J, Hustinx, R 2003Imaging gliomas with positron emission tomography and single-photon emission computed tomography.Semin Nucl Med33148162CrossRefPubMedGoogle Scholar
  7. Brem, S, Cotran, R, Folkman, J 1972Tumor angiogenesis: a quantitative method for histologic grading.J Natl Cancer Inst48347356PubMedGoogle Scholar
  8. Bruening, R, Kwong, KK, Vevea, MJ 1996Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.AJNR17831840PubMedGoogle Scholar
  9. Dean, BL, Drayer, BP, Bird, CR 1990Gliomas Classification with MR imaging.Radiology174411415PubMedGoogle Scholar
  10. Di Chiro, G, De LaPaz, RL, Brooks, RA, Sokoloff, L, Kornblith, PL, Smith, BH, Patronas, NJ, Kufta, CV, Kessler, RM, Johnston, GS, Manning, RG, Wolf, AP 1982Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.Neurology3213231329PubMedGoogle Scholar
  11. Fountas, KN, Kapsalaki, EZ, Vogel, RL, Fezoulidis, I, Robinson, JS, Gotsis, ED 2004Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy.Stereotact Funct Neurosurg929097Google Scholar
  12. Ginsberg, LE, Fuller, GN, Hashmi, M, Leeds, NE, Schomer, DF 1998The Significance of Lack of MR Contrast Enhancement of Supratentorial Brain Tumors in Adults: Histopathological Evaluation of a Series.Surg Neurol49436440PubMedGoogle Scholar
  13. Henry, RG, Vigneron, DB, Fischbein, NJ, Grant, PE, Day, MR, Noworolski, SM, Star-Lack, JM, Wald, LL, Dillon, WP, Chang, SM, Nelson, SJ 2000Comparison of Relative Cerebral Blood Volume and Proton Spectroscopy in Patients with Treated Gliomas.AJNR21357366PubMedGoogle Scholar
  14. Jackson, A, Kassner, A, Annesley-Williams, D, Reid, H, Zhu, X-P, Li, K-L 2002Abnormalities in the Recirculation Phase of Contrast Agent Bolus Passage in Cerebral Gliomas: comparison with Relative Blood Volume and Tumor Grade.AJNR23714PubMedGoogle Scholar
  15. Kleihues P, Cavenee WK (eds) (2000) World Health Organisation classification of tumours: pathology and genetics of tumours of the nervous system. IARC Press, LyonGoogle Scholar
  16. Knopp, EA, Cha, S, Johnson, G, Mazumdar, A, Golfinos, JG, Zagzag, D, Miller, DC, Kelly, PJ, Kricheff, II 1999Glial neoplasms: dynamic contrast-enhanced T2-weighted MR imaging.Radiology211791798PubMedGoogle Scholar
  17. Kondziolka, D, Lunsford, LD, Martinez, AJ 1993Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma.J Neurosurg79533536PubMedGoogle Scholar
  18. Kremer, S, Grand, S, Remy, C, Esteve, F, Lefournier, V, Pasquier, B, Hoffmann, D, Benabid, AL, Le Bas, JF 2002Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors.J Neuroradiol29105113PubMedGoogle Scholar
  19. Kuznetzov, YE, Caramanos, Z, Antel, SB, Preul, MC, Leblanc, R, Villemure, JG, Pokrupa, R, Olivier, A, Sadikot, A, Arnold, DL 2003Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas.Neurosurgery53565574Google Scholar
  20. Law, M, Yang, S, Babb, JS, Knopp, EA, Golfinos, JG, Zagzag, D, Johnson, G 2004Comparison of Cerebral Blood Volume and Vascular Permeability from Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging with Glioma Grade.AJNR25746755PubMedGoogle Scholar
  21. Law, M, Yang, S, Wang, H, Babb, JS, Johnson, G, Cha, S, Knopp, EA, Zagzag, D 2003Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.AJNR Am J Neuroradiol2419891998PubMedGoogle Scholar
  22. Lefournier, V, Peoc’h, M, Usson, Y, Bosson, JL, Grand, S, Pasquier, B, Le Bas, JF 2003Magnetic resonance cerebral blood volume maps. Comparison with histologic findings in different types of brain lesions.J Neuroradiol3039PubMedGoogle Scholar
  23. Leon, SP, Folkerth, RD, Black, PM 1996Microvessel density is a prognostic indicator for patients with astroglial brain tumors.Cancer77362372CrossRefPubMedGoogle Scholar
  24. Lev, MH, Ozsunar, Y, Henson, JW, Rasheed, AA, Barest, GD, GR, Harsh,4th, Fitzek, MM, Chiocca, EA, Rabinov, JD, Csavoy, AN, Rosen, BR, Hochberg, FH, Schaefer, PW, Gonzalez, RG 2004Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas.AJNR25214221PubMedGoogle Scholar
  25. Ludemann, L, Grieger, W, Wurm, R, Budzisch, M, Hamm, B, Zimmer, C 2001Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas.Eur Radiol1112311241PubMedGoogle Scholar
  26. Maeda, M, Itoh, S, Kimura, H, Iwasaki, T, Hayashi, N, Yamamoto, K, Ishii, Y, Kubota, T 1993Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging.Radiology189233238PubMedGoogle Scholar
  27. Maia, ACM,Jr, Malheiros, SMF, Da Rocha, AJ, Stavale, JN, Guimaraes, IF, Borges, LRR, Santos, AJ, Da Silva, CJ, De Melo, JGSP, Lanzoni, OP, Gabbai, AA, Ferraz, FAP 2004Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging.J Neurosurg101970976PubMedGoogle Scholar
  28. Majos, C, Alonso, J, Aguilera, C, Serrallonga, M, Perez-Martin, J, Acebes, JJ, Arus, C, Gili, J 2003Proton magnetic resonance spectroscopy ((1)H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization.Eur Radiol13582591PubMedGoogle Scholar
  29. Martin, WH, Delbeke, D, Patton, JA 1996Detection of malignancies with SPECT versus PET, with 2-[fluorine-18] fluoro-2-deoxy-D-glucose.Radiology198225231PubMedGoogle Scholar
  30. Naëgele, T, Petersen, D, Klose, U 1993Dynamic contrast enhancement of intracranial tumors with snapshot-FLASH MR imaging.AJNR148998Google Scholar
  31. Nafe, R, Herminghaus, S, Pilatus, U, Hattingen, E, Marquardt, G, Scholte, W, Lanfermann, H, Zanella, F 2004Morphology of proliferating and non-proliferating tumor cell nuclei in glioblastomas correlates with preoperative data from proton-MR-spectroscopy.Neuropathology24172182CrossRefPubMedGoogle Scholar
  32. Ogawa, T, Inugami, A, Hatazawa, J 1996Clinical positron emission tomography for brain tumors: comparison of fluorodeoxyglucose F18 and L-methyl C-methionone.AJNR Am J Neuroradiol17345353PubMedGoogle Scholar
  33. Oh, J, Henry, RG, Pirzkall, A, Lu, Y, Li, X, Catalaa, I, Chang, S, Dillon, WP, Nelson, SJ 2004Survival analysis in patients with glioblastoma multiforme: predictive value of Choline-to-N-Acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume.J Magn Reson Imaging19546554CrossRefPubMedGoogle Scholar
  34. Padma, MV, Said, S, Jacobs, M, Hwang, DR, Dunigan, K, Satter, M, Christian, B, Ruppert, J, Bernstein, T, Kraus, G, Mantil, JC 2003Prediction of pathology and survival by FDG PET in gliomas.J Neurooncol64227237CrossRefPubMedGoogle Scholar
  35. Perkio, J, Aronen, HJ, Kangasmaki, A, Liu, Y, Karonen, J, Savolainen, S, Ostergaard, L 2002Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging.Magn Reson Med47973981PubMedGoogle Scholar
  36. Plotkin, M, Eisenacher, J, Bruhn, H, Wurm, R, Michel, R, Stockhammer, F, Feussner, A, Dudeck, O, Wust, P, Felix, R, Amthauer, H 2004123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.J Neurooncol704958CrossRefPubMedGoogle Scholar
  37. Preul, C, Kühn, B, Lang, EW, Mehdorn, HM, Heller, M, Link, J 2003Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging European.J Radiology48244251Google Scholar
  38. Provenzale, JM, Wang, GR, Brenner, T, Petrella, JR, Sorensen, AG 2002Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.AJR Am J Roentgenol178711716PubMedGoogle Scholar
  39. Pruim, J, Willemsen, AT, Molenaar, WM 1995Brain tumors: L-[1-C-11] tyrosine PET for visualization and quantification of protein synthesis rate.Radiology197221226PubMedGoogle Scholar
  40. Roberts, HC, Roberts, TP, Brasch, RC, Dillon, WP 2000Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.AJNR Am J Neuroradiol21891899PubMedGoogle Scholar
  41. Rosen, BR, Belliveau, JW, Vevea, JM 1990Perfusion imaging with NMR contrast agents.Magn Reson Med14249265PubMedGoogle Scholar
  42. Sasaki, M, Kuwabara, Y, Yoshida, T, Nakagawa, M, Fukumura, T, Mihara, F, Morioka, T, Fukui, M, Masuda, K 1998A comparative study of thallium-201 SPECT, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.Eur J Nucl Med2512611269CrossRefPubMedGoogle Scholar
  43. Shin, JH, Lee, HK, Kwun, BD, Kim, JS, Kang, W, Choi, CG, Suh, DC 2002Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.AJR179783789PubMedGoogle Scholar
  44. Siegal, T, Rubinstein, R, Tzuk-Shina, T, Gomori, JM 1997Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors.J Neurosurg862227PubMedGoogle Scholar
  45. Sugahara, T, Korogi, Y, Kochi, M, Ikushima, I, Hirai, T, Okuda, T, Shigematsu, Y, Liang, L, Ge, Y, Ushio, Y, Takahashi, M 1998Correlation of MR Imaging-Determined Cerebral Blood Volume Maps with Histologic and Angiographic Determination of Vascularity of Gliomas.AJR17114791486PubMedGoogle Scholar
  46. Tamura, M, Shibasaki, T, Zama, A, Kurihara, H, Horikoshi, S, Ono, N, Oriuchi, N, Hirano, T 1998Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride.Neuroradiology40210215CrossRefPubMedGoogle Scholar
  47. Tedeschi, G, Lundbom, N, Raman, R, Bonavita, S, Duyn, JH, Alger, JR, Di Chiro, G 1997Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.J Neurosurg87516524PubMedGoogle Scholar
  48. Watanabe, M, Tanaka, R, Takeda, N 1992Magnetic resonance imaging and histopathology of cerebral gliomas.Neuroradiology34463469PubMedGoogle Scholar
  49. Yang, D, Korogi, Y, Sugahara, T, Kitajima, M, Shigematsu, Y, Liang, L, Ushio, Y, Takahashi, M 2002Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.Neuroradiology44656666PubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2006

Authors and Affiliations

  • C. Chaskis
    • 1
  • T. Stadnik
    • 2
  • A. Michotte
    • 3
  • K. Van Rompaey
    • 1
  • J. D’Haens
    • 1
  1. 1.Department of NeurosurgeryAcademic Hospital, Vrije Universiteit BrusselBrusselsBelgium
  2. 2.Department of NeuroimagingAcademic Hospital, Vrije Universiteit BrusselBrusselsBelgium
  3. 3.Department of NeuropathologyAcademic Hospital, Vrije Universiteit BrusselBrusselsBelgium

Personalised recommendations